Acertannin Prevented Dextran Sulfate Sodium-induced Colitis by Inhibiting the Colonic Expression of IL-23 and TNF-α in C57BL/6J Mice
Planta Medica · 01.06.2023 · 89 (07) · 746-753
DOI: 10.1055/a-2037-2995 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.06.2023. Verfasst von Yoshiyuki Kimura und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Sciences, Osaka Medical and Pharmaceutical University, Nasahara, Takatsuki, Osaka, Japan. Hauptthemen laut MEDLINE: Tumor Necrosis Factor-alpha, Colitis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science (JSPS) KAKENHI.
Abstract (Originalsprache)
The present study investigates the effects of acertannin on colitis induced by dextran sulfate sodium (DSS) and changes in the colonic levels of the cytokines interleukin (IL)-1β, IL-6, IL-10, IL-23, tumor necrosis factor (TNF)-α, the chemokine monocyte chemoattractant protein (MCP)-1, and vascular endothelial growth factor (VEGF). We examine the following: inflammatory colitis was induced in mice by 2% DSS drinking water given ad libitum for 7 days. Red blood cell, platelets, and leukocyte counts and hematocrit (Ht), hemoglobin (Hb), and colonic cytokine and chemokine levels were measured. The disease activity index (DAI) was lower in DSS-treated mice orally administered acertannin (30 and 100 mg/kg) than in DSS-treated mice. Acertannin (100 mg/kg) inhibited reductions in the red blood cell count and Hb and Ht levels in DSS-treated mice. Acertannin prevented DDS-induced mucosal membrane ulceration of the colon and significantly inhibited the increased colonic levels of IL-23 and TNF-α. Our findings suggest that acertannin has potential as a treatment for inflammatory bowel disease (IBD).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmaceutical Sciences, Osaka Medical and Pharmaceutical University, Nasahara, Takatsuki, Osaka, Japan.
- Previous affiliation: Department of Functional Biomedicine, Ehime University Graduate School of Medicine, Toon, Ehime, Japan.
- Faculty of Pharmaceutical Sciences, Okayama University, Tsushima, Okayama, Japan.
ORCID-Profile: Yoshiyuki Kimura
Förderung
- Japan Society for the Promotion of Science (JSPS) KAKENHI
Zitieren
APA
Kimura, Y., Taniguchi, M., & Okuda, T. (2023). Acertannin Prevented Dextran Sulfate Sodium-induced Colitis by Inhibiting the Colonic Expression of IL-23 and TNF-α in C57BL/6J Mice. Planta Medica, 89(07), 746-753. https://doi.org/10.1055/a-2037-2995
Vancouver
Kimura Y, Taniguchi M, Okuda T. Acertannin Prevented Dextran Sulfate Sodium-induced Colitis by Inhibiting the Colonic Expression of IL-23 and TNF-α in C57BL/6J Mice. Planta Medica. 2023;89(07):746-753. doi:10.1055/a-2037-2995
BibTeX
@article{Kimura2023,
author = {Kimura, Yoshiyuki and Taniguchi, Masahiko and Okuda, Takuo},
title = {Acertannin Prevented Dextran Sulfate Sodium-induced Colitis by Inhibiting the Colonic Expression of IL-23 and TNF-α in C57BL/6J Mice},
journal = {Planta Medica},
year = {2023},
volume = {89},
number = {07},
pages = {746--753},
doi = {10.1055/a-2037-2995}
}
EUVIMED